#medical needs

Collection of medical needs news, found 62 news.

Aptorum Group commences commercialization of dioscorea opposita bioactive nutraceutical tablets and signed sales distribution agreement in Hong Kong

- Aptorum Group Limited (“Aptorum Group”), a pharmaceutical company focused on the development of novel ...

Aptorum Group announces significant progress of repurposed drug candidate, SACT-1 for neuroblastoma targeting IND submission in H2 2020

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group announces further positive data for its ALS-4 small molecule Anti-virulence (Non-bactericidal) drug candidate for the treatment of infections caused by Staphylococcus aureus and on track

- Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group has initiated IND-enabling studies for its ALS-4 small molecule candidate for the treatment of infections caused by staphylococcus aureus including MRSA

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group announces the development of microbiome drug candidate targeting obesity and repurposed drug candidates targeting neuroblastoma

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group’s subsidiary Smart Pharma announces Smart Pharma token (SMPT) to be listed on IDAX and LATOKEN

- Aptorum Group Limited (Nasdaq: APM) subsidiary Smart Pharmaceutical is excited to announce that the Smart Pharma ...

Terns Pharmaceuticals announces exclusive licensing and collaboration agreement with GENFIT to develop and commercialize elafibranor in the Greater China region

- Terns Pharmaceuticals, Inc. today announced an exclusive licensing and collaboration agreement with GENFIT (GNFT), a ...

Aeneas Capital and Pyrinas target launch of US$120m fund to develop co-working laboratory ecosystems for life sciences start-ups in the United States

    • Aeneas Capital and Pyrinas, both affiliated companies to Aptorum Group Ltd (Nasdaq: APM), is ...

Aptorum Group establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and unmet Diseases

- Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma ...

Widodo signs regulation on safety, security of president-vice presidential candidates

President Joko Widodo has signed a Presidential Regulation (Perpres) Number 85 of 2018 concerning the safety and ...

Clinigen signs agreement with Nordic Pharma for aprotinin

- Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global pharmaceutical and services company, has signed an agreement ...

Celularity, Inc., accelerates breakthrough placental discovery & therapeutic platform

- Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue ...

Britain`s health service in "humanitarian crisis": Red Cross

Britains health service is engulfed in a "humanitarian crisis" that requires the support of the Red Cross to use Land ...

Johnson & Johnson Innovation - JJDC Makes $15 Million Investment in Vivo Capital Fund

- Johnson & Johnson Innovation - JJDC, Inc. (JJDC) today announced a USD $15 million commitment to Vivo Capital ...

Ansell Announces Record Product Donation To Direct Relief In Response To Typhoon Haiyan In The Philippines

- Ansell (ASX: ANN), a global leader in protection solutions, today announced that it has donated medical and ...